Michael Hartmann

Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group

Peter Albers, Roswitha Siener, S. Krege et al. · Journal of Clinical Oncology · 2008 · 340 citations

Medicine, Oncology, Surgery +14

Risk Factors for Relapse in Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: Results of the German Testicular Cancer Study Group Trial

Peter Albers, Roswitha Siener, Sabine Kliesch et al. · Journal of Clinical Oncology · 2003 · 318 citations

Medicine, Oncology, Surgery +17

Hospital Incidence and Mortality Rates of Sepsis: An Analysis of Hospital Episode (DRG) Statistics in Germany From 2007 to 2013

Carolin Fleischmann-Struzek, Michael Hartmann, Christiane S. Hartog et al. · Deutsches Ärzteblatt international · 2016 · 273 citations

Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +11

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

S. Krege, Rainer Souchon, Peter Albers et al. · European Urology · 2008 · 252 citations

Medicine, Cancer Biology, Oncology +17

Complications of Primary Nerve Sparing Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Experience of the German Testicular Cancer Study Group

Axel Heidenreich, Peter Albers, Michael Hartmann et al. · The Journal of Urology · 2003 · 244 citations

Medicine, Oncology, Surgery +11